Design Therapeutics, Inc. (DSGN) stock
DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.84−0.08 (-0.81%)
Close on Nov 17, 2026Market cap $615.80MP/E –Yield –
Design Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Design Therapeutics's operating margin for the twelve months ending Dec 31, 2020 was -3685.8%. For fiscal 2020 it was -3685.8%.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -3685.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | -11700.0% | – |
| Q3 FY2020 | Sep 30, 2020 | -11915.0% | – |
| Q2 FY2020 | Jun 30, 2020 | -4719.4% | – |
| Q1 FY2020 | Mar 31, 2020 | -438.7% | – |
See a number that looks wrong?